Gynecology Tablet Franchise in Ahmedabad

Medroxyprogesterone Acetate Tablet Supplier in Mumbai

Hormonal Therapy Tablet Distributor in Delhi

Women Health Pharma Franchise in Bangalore

Progesterone Tablet Stockist in Hyderabad
Gynecology Tablet Manufacturer & Exporter in Chandigarh

Home/Products /medroxyprogesterone-acetate-30mg-tablet

Peblegest M 30 tablet

Composition : Medroxyprogesterone acetate (30mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Peblegest M 30 Tablet contains Medroxyprogesterone Acetate 30 mg, a synthetic progesterone widely used in the management of menstrual irregularities, hormonal imbalance, and gynecological disorders. It plays a key role in regulating the menstrual cycle and maintaining hormonal stability.

Medroxyprogesterone Acetate works by restoring progesterone levels, helping to control abnormal uterine bleeding, support endometrial health, and manage conditions such as amenorrhea and endometriosis. Its targeted hormonal action ensures effective symptom control and improved reproductive health outcomes.

Clinically, Peblegest M 30 Tablet is prescribed in secondary amenorrhea, dysfunctional uterine bleeding, endometriosis, and hormone replacement protocols, offering reliable efficacy and consistent therapeutic response.

From a portfolio perspective, Peblegest M 30 Tablet strengthens the gynecology and women’s health segment, with regular demand across clinics, hospitals, and specialty gynecological practices, supporting long-term prescription continuity and therapeutic relevance.


Read More

About the Product

Peblegest M 30 Tablet contains Medroxyprogesterone Acetate 30 mg, a synthetic progesterone widely used in the management of menstrual irregularities, hormonal imbalance, and gynecological disorders. It plays a key role in regulating the menstrual cycle and maintaining hormonal stability.

Medroxyprogesterone Acetate works by restoring progesterone levels, helping to control abnormal uterine bleeding, support endometrial health, and manage conditions such as amenorrhea and endometriosis. Its targeted hormonal action ensures effective symptom control and improved reproductive health outcomes.

Clinically, Peblegest M 30 Tablet is prescribed in secondary amenorrhea, dysfunctional uterine bleeding, endometriosis, and hormone replacement protocols, offering reliable efficacy and consistent therapeutic response.

From a portfolio perspective, Peblegest M 30 Tablet strengthens the gynecology and women’s health segment, with regular demand across clinics, hospitals, and specialty gynecological practices, supporting long-term prescription continuity and therapeutic relevance.


Common side effects may include nausea, headache, breast tenderness, bloating, weight changes, or mood alterations. Rarely, allergic reactions, thromboembolic events, or changes in blood pressure may occur.

Peblegest M 30 Tablet is indicated for the treatment of menstrual disorders, including secondary amenorrhea, dysfunctional uterine bleeding, and irregular menstrual cycles. It is also used in the management of endometriosis and as part of hormone therapy in specific conditions, as prescribed by a healthcare professional.

Use Peblegest M 30 Tablet strictly as directed by a physician. Inform your doctor of any history of liver disease, thromboembolic disorders, or hormone-sensitive cancers. Do not use during pregnancy. Discontinue use and seek medical advice if unusual vaginal bleeding, severe headache, or leg swelling occurs.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation